AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding AIM ImmunoTech Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 38 | 40 | +2 |
| Shares | 6.72M | 6.01M | −711.1K (−10.6%) |
| Value | $7.12M | $4.68M | −$2.44M (−34.2%) |
New holders (7)
Institutions that held AIM ImmunoTech Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Raymond James Financial Services Advisors, Inc. | 37,450 | $29.0K | 0.00% |
| Two Sigma Securities, LLC | 31,142 | $24.0K | 0.00% |
| ForthRight Wealth Management, LLC | 20,000 | $16.0K | 0.01% |
| Susquehanna International Group, LLP | 19,070 | $15.0K | 0.00% |
| Jane Street Group, LLC | 10,396 | $8.00K | 0.00% |
| Credit Suisse AG | 9 | $0 | 0.00% |
| New Millennium Group LLC | 33 | $0 | 0.00% |
Sold out (5)
Institutions that held AIM ImmunoTech Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Dimensional Fund Advisors LP | 83,557 | $89.0K |
| Millennium Management LLC | 13,033 | $14.0K |
| Schonfeld Strategic Advisors LLC | 10,800 | $11.0K |
| Howe & Rusling Inc | 1,500 | $2.00K |
| Royal Bank of Canada | 1 | $0 |